Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Troost coffee shop ‘broken into pieces’ by collision; caffeinated supporters jump to action
A community of customers and neighbors is rallying behind Anchor Island Coffee this week after a pickup truck barreled into the front entrance of the tropical-themed breakfast spot at 41st and Troost. Fortunately no one was injured in the after-hours incident, said co-owner Armando Vasquez, who noted he was the last person to leave the…
KC innovator’s anti-itch spray so natural it was discovered on a front porch lab
Homindy founder Ronan Molloy discovered the benefits of his company’s itch relief spray somewhat by accident. During the summer of 2020, Molloy volunteered to participate in a clinical study for a tea with all-natural ingredients that was supposed to reduce inflammation in his right knee. At that time, he was president of the Innovation Stockyard,…
KC capital implants cattle tech startup with fuel to scale, expanding IVF labs, headcount
Livestock production has seen a remarkable transformation since Kerryann Kocher was growing up on her family’s sixth-generation farm in northeast Iowa, the Vytelle CEO said. Instead of just selecting the cow that looks best and bringing in the neighbor’s bull for breeding, as she remembers it, Kocher and Vytelle — a Kansas City-based precision livestock…
Venture experts: Getting your first check in KC is too difficult, but a record influx of coastal investors isn’t a bad substitute
A new report on Kansas City’s venture-backed companies showed year-over-year growth in multiple areas — impressing industry experts who identified key investment trends in the data. More companies with venture capital backing; higher employee counts; a 58 percent boost in fundraising. Yet growth was not universal. Despite gains in top-line figures, the number of Kansas City-based…